Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors GlobeNewswire Aug 28, 2024 12:00pm
Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire Aug 14, 2024 8:30pm
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma GlobeNewswire Aug 12, 2024 11:00am